Even though last week saw just one initial public offering (IPO), the month of May produced a total of 20 IPOs and raised $4.3 billion. That is just one less than the 21 IPOs in May of 2014 and $600 million less in total proceeds.

IPO ETF manager Renaissance Capital reported that 69 IPOs have priced in the United States so far this year, down 40% from a year ago. Total proceeds raised through May 28 equaled $12.3 billion, down almost 48% compared with the same period in 2014. Of the 69 IPOs that have gone off this year, 31 have come from the health care sector. Last year’s IPO total came in at $85.2 billion, the highest total in the past 10 years. Renaissance Capital does not include “best efforts” or blank check companies in its totals.

Last week’s lone IPO came from Corindus Vascular Robotics Inc. (NYSEMKT: CVRS), which sold 11 million shares at $3.80 per share. The company had previously traded on the OTC market under the same symbol.

There are four companies expected to price IPOs in the coming week. One is a midstream energy partnership, two are health care companies and one is a tea retailer.

PennTex Midstream Partners is a limited partnership that is being formed to hold and operate midstream natural gas-related assets in northern Louisiana. The company plans to 11.3 million partnership units in an expected price range of $19 to $21 per unit to raise $225 million at a market cap of around $800 million. Joint bookrunners for the offering include Citigroup, Barclays, RBC Capital Markets, Wells Fargo Securities, Deutsche Bank, JPMorgan, Suntrust Robinson Humphrey, as well as Tudor, Pickering, Holt. Co-managers include Raymond James, Baird, Stifel and Wunderlich Securities. Common units are set to price on Wednesday and begin trading Thursday on the Nasdaq under the ticker symbol PTXP.

ALSO READ: 10 Stocks to Own for the Next Decade

DAVIDs Tea is an Ottawa, Canada-based company that operates 158 retail stores and a website selling loose-leaf teas, prepackaged teas, tea sachets and tea-related gifts and accessories. The company plans to offer 5.1 million shares in an IPO price range of $14 to $16, raising $76.5 million at a market cap of $388 million. Joint bookrunners for the offering are Goldman Sachs, JPMorgan and Bank of America Merrill Lynch. Co-managers are BMO Capital Markets and William Blair. Shares are set to price on Thursday and begin trading Friday on the Nasdaq under the ticker symbol DTEA.

EndoChoice Holdings (ECPM Holdings) is a medical device company that designs and commercializes products and services for gastrointestinal caregivers. The company plans to offer 6.3 million shares in an expected price range of $15 to $17 to raise $100 million at a market cap of $396 million. Joint bookrunners for the IPO are JPMorgan and Merrill Lynch. Co-managers are William Blair and Stifel. Shares are set to price on Thursday and begin trading Friday on the New York Stock Exchange under the ticker symbol GI.

Evolvent Health provides a platform for health care providers that joins financially responsible, clinical treatment into value-based care for patients. The company plans to offer 10 million shares in an expected range of $14 to $16 to raise $150 million at a market cap of around $837 million. Joint bookrunners for the offering are JPMorgan and Goldman Sachs. Co-managers include Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners. The shares are set to price on Thursday and begin trading Friday on the New York Stock Exchange under the ticker symbol EVH.

ALSO READ: 5 Key Analyst Stock Picks With 50% to 100% Upside (or Even More)

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.